• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体膜攻击复合物调节因子CD59在人骨骼肌纤维上的表达。

Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.

作者信息

Navenot J M, Villanova M, Lucas-Héron B, Malandrini A, Blanchard D, Louboutin J P

机构信息

Etablissement de Transfusion Sanguine Loire-Atlantique-Vendée, Nantes,France.

出版信息

Muscle Nerve. 1997 Jan;20(1):92-6. doi: 10.1002/(sici)1097-4598(199701)20:1<92::aid-mus12>3.0.co;2-3.

DOI:10.1002/(sici)1097-4598(199701)20:1<92::aid-mus12>3.0.co;2-3
PMID:8995588
Abstract

Control of complement deposition on autologous cells is mediated by a group of complement regulatory membrane proteins acting at different levels of the complement cascade. Decay accelerating factor (CD55) prevents the assembly of C3 convertases and CD59 membrane inhibitor of reactive lysis (MIRL) restricts homologous complement lysis by the membrane attack complex of complement (MAC) by inhibition of C5b-8 catalyzed insertion of C9. The aim of this work was to study the eventual expression of CD55 and CD59 on human skeletal muscle fibers. Highly sensitive immunoblotting using murine monoclonal antibodies showed that CD59, but not CD55, was present in skeletal muscle fibers. Immunocytochemistry with a monoclonal antibody against CD59 demonstrated a dense granular immunostaining mainly localized at the level of the sarcolemma. Thus, CD59, but not CD55, is expressed on normal skeletal muscle fibers. CD59 may play a prominent role in preventing MAC deposition and subsequent complement-mediated damage in myopathies where the complement system activation is involved.

摘要

补体在自体细胞上的沉积调控是由一组补体调节膜蛋白介导的,这些蛋白作用于补体级联反应的不同水平。衰变加速因子(CD55)可阻止C3转化酶的组装,而CD59膜反应性溶解抑制因子(MIRL)通过抑制C5b-8催化的C9插入,限制补体膜攻击复合物(MAC)引起的同源补体溶解。本研究的目的是探讨CD55和CD59在人骨骼肌纤维上的最终表达情况。使用鼠单克隆抗体进行的高度敏感免疫印迹显示,骨骼肌纤维中存在CD59,但不存在CD55。用抗CD59单克隆抗体进行的免疫细胞化学显示,密集的颗粒状免疫染色主要位于肌膜水平。因此,正常骨骼肌纤维上表达的是CD59而非CD55。在涉及补体系统激活的肌病中,CD59可能在防止MAC沉积及随后的补体介导损伤方面发挥重要作用。

相似文献

1
Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.补体膜攻击复合物调节因子CD59在人骨骼肌纤维上的表达。
Muscle Nerve. 1997 Jan;20(1):92-6. doi: 10.1002/(sici)1097-4598(199701)20:1<92::aid-mus12>3.0.co;2-3.
2
Isolation and functional assay of the membrane complement inhibitors CD55 (DAF) and CD59 (MIRL).膜补体抑制剂CD55(衰变加速因子)和CD59(膜攻击复合物抑制因子)的分离及功能测定
Curr Protoc Immunol. 2001 May;Chapter 13:13.5.1-13.5.18. doi: 10.1002/0471142735.im1305s11.
3
Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.人类髓磷脂和神经胶质细胞上的补体调节分子:差异表达影响活化补体蛋白的沉积。
J Neurochem. 1996 Jan;66(1):303-12. doi: 10.1046/j.1471-4159.1996.66010303.x.
4
Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.siRNA 抑制膜补体抑制剂表达(CD46、CD55、CD59)可使肿瘤细胞在体外对补体攻击敏感。
Curr Cancer Drug Targets. 2010 Dec;10(8):922-31. doi: 10.2174/156800910793357952.
5
CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.CD59不仅能阻止C9插入膜攻击复合物(MAC),还能抑制同源的C5b - 8以及C5b - 9形成离子通道。
J Physiol. 2002 Mar 1;539(Pt 2):537-45. doi: 10.1113/jphysiol.2001.013381.
6
The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).在缺乏保护素(CD59)的情况下,终末补体复合物在慢性腿部溃疡中生成。
APMIS. 1999 Nov;107(11):997-1004. doi: 10.1111/j.1699-0463.1999.tb01502.x.
7
Critical protection from renal ischemia reperfusion injury by CD55 and CD59.CD55和CD59对肾脏缺血再灌注损伤的关键保护作用。
J Immunol. 2004 Mar 15;172(6):3869-75. doi: 10.4049/jimmunol.172.6.3869.
8
Trimeresurus flavoviridis (habu snake) venom induces human erythrocyte lysis through enzymatic lipolysis, complement activation and decreased membrane expression of CD55 and CD59.竹叶青蛇毒通过酶促脂解、补体激活以及降低CD55和CD59的膜表达诱导人红细胞溶解。
Pharmacol Toxicol. 2001 Oct;89(4):188-94. doi: 10.1111/j.0901-9928.2001.890408.x.
9
Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.Crry,而非CD59和衰变加速因子(DAF),对于小鼠红细胞在体内免受自发补体攻击至关重要。
Blood. 2002 May 15;99(10):3707-16. doi: 10.1182/blood.v99.10.3707.
10
Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.细胞补体抑制剂 CD59、CD46 和 CD55 对副流感病毒 5 抑制补体介导的中和作用的相对贡献。
Viruses. 2018 Apr 25;10(5):219. doi: 10.3390/v10050219.

引用本文的文献

1
CD59 Expression in Skeletal Muscles and Its Role in Myasthenia Gravis.CD59 在骨骼肌中的表达及其在重症肌无力中的作用。
Neurol Neuroimmunol Neuroinflamm. 2022 Nov 17;10(1). doi: 10.1212/NXI.0000000000200057. Print 2023 Jan.
2
Association of Blood Group Antigen CD59 with Disease.血型抗原CD59与疾病的关联。
Transfus Med Hemother. 2022 Jan 13;49(1):13-24. doi: 10.1159/000521174. eCollection 2022 Feb.
3
The emerging role of complement in neuromuscular disorders.补体系统在神经肌肉疾病中的新作用。
Semin Immunopathol. 2021 Dec;43(6):817-828. doi: 10.1007/s00281-021-00895-4. Epub 2021 Oct 27.
4
Complement Inhibition for the Treatment of Myasthenia Gravis.补体抑制治疗重症肌无力
Immunotargets Ther. 2020 Dec 15;9:317-331. doi: 10.2147/ITT.S261414. eCollection 2020.
5
Complement Inhibitor Therapy for Myasthenia Gravis.补体抑制剂治疗重症肌无力。
Front Immunol. 2020 Jun 3;11:917. doi: 10.3389/fimmu.2020.00917. eCollection 2020.
6
The role of complement in experimental autoimmune myasthenia gravis.补体在实验性自身免疫性重症肌无力中的作用。
Ann N Y Acad Sci. 2012 Dec;1274(1):127-32. doi: 10.1111/j.1749-6632.2012.06783.x.
7
Effect of complement and its regulation on myasthenia gravis pathogenesis.补体及其调节在重症肌无力发病机制中的作用。
Expert Rev Clin Immunol. 2008 Jan;4(1):43-52. doi: 10.1586/1744666X.4.1.43.
8
Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?眼外肌对重症肌无力的易感性:独特的免疫环境?
Ann N Y Acad Sci. 2008;1132:220-4. doi: 10.1196/annals.1405.037.
9
Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.重症肌无力胸腺:上皮细胞和肌样细胞的补体易损性、补体对它们的攻击以及与自身抗体状态的相关性。
Am J Pathol. 2007 Sep;171(3):893-905. doi: 10.2353/ajpath.2007.070240. Epub 2007 Aug 3.
10
Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs.柯萨奇病毒和腺病毒受体(CAR)在神经肌肉接头和心脏闰盘中的异构体特异性表达。
BMC Cell Biol. 2004 Nov 8;5(1):42. doi: 10.1186/1471-2121-5-42.